Drug recall · September 6, 2023
dilTIAZem 125mg/125mL recall
Why: Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
dilTIAZem 125mg/125mL (1 mg/mL), added to 0.9% sodium chloride, IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6055-1
- Lots / codes
Lot# 36-262537, Exp 9/19/2023. ;
- Quantity
- 235 bags
- Company
- Central Admixture Pharmacy Services, Inc., Phoenix, AZ
- Distribution
- Nationwide in the USA
- Initiated
- August 17, 2023 · Voluntary: Firm initiated
- Classified
- August 28, 2023
- Reported
- September 6, 2023
- Ended
- March 27, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diltiazem
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.